A dual role for adeno-associated virus in human health
Abstract Adeno-associated virus (AAV) differs from most other viruses, as it requires the simultaneous presence of a helper virus for an active infection. Up to 80% of the human population is seropositive for AAV antibodies. AAV has been known to be a non-pathogenic virus and an inhibitor of carcino...
Main Author: | Natalia M Araujo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12985-023-02196-8 |
Similar Items
-
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
by: Nadja Meumann, et al.
Published: (2022-01-01) -
Advances in adeno-associated virus mediated gene therapy in tumors
by: YANG Xiao-juan, LI Zhen-hao, GOU Yuan-feng, HUO Xia-qin, PEI Ya-ping, LI Na, LIU Hui-ling
Published: (2021-04-01) -
Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma
by: Meead Hadi, et al.
Published: (2024-01-01) -
Battling Neurodegenerative Diseases with Adeno-Associated Virus-Based Approaches
by: Olja Mijanović, et al.
Published: (2020-04-01) -
Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
by: Prabhakar Bastola, et al.
Published: (2020-08-01)